Evaluation of kinesthetic-tactual displays using a critical tracking task

The study sought to investigate the feasibility of applying the critical tracking task paradigm to the evaluation of kinesthetic-tactual displays. Four subjects attempted to control a first-order unstable system with a continuously decreasing time constant by using either visual or tactual unidimensional displays. Display aiding was introduced in both modalities in the form of velocity quickening. Visual tracking performance was better than tactual tracking, and velocity aiding improved the critical tracking scores for visual and tactual tracking about equally. The results suggest that the critical task methodology holds considerable promise for evaluating kinesthetic-tactual displays

Quasideterminant solutions of a non-Abelian Hirota-Miwa equation

A non-Abelian version of the Hirota-Miwa equation is considered. In an earlier paper [Nimmo (2006) J. Phys. A: Math. Gen. \textbf{39}, 5053-5065] it was shown how solutions expressed as quasideterminants could be constructed for this system by means of Darboux transformations. In this paper we discuss these solutions from a different perspective and show that the solutions are quasi-Pl\"{u}cker coordinates and that the non-Abelian Hirota-Miwa equation may be written as a quasi-Pl\"{u}cker relation. The special case of the matrix Hirota-Miwa equation is also considered using a more traditional, bilinear approach and the techniques are compared

Overlooked gall-inducing moths revisited, with the description of Andescecidium parrai gen. et sp. n. and Oliera saizi sp. n. from Chile (Lepidoptera, Cecidosidae)

There are still many gall systems associated with larvae of Lepidoptera in which the true gall-inducers have not been identified to species. Reports on misidentification of gall inducers have been recurrent for these galls, particularly in complex gall-systems that may include inquilines, kleptoparasites, and cecidophages, among other feeding guilds such as predators and parasitoid wasps. Here we describe and illustrate the adults, larvae, pupae and galls, based on light and scanning microscopy, of Andescecidium parrai gen. et sp. n. and Oliera saizi sp. n., two sympatric cecidosid moths that are associated with Schinus polygamus (Cav.) Cabrera (Anacardiaceae) in central Chile. Adults, immatures, and galls of the former did not conform to any known cecidosid genus. Galls of A. parrai are external, spherical, and conspicuous, being known for more than one century. However, their induction has been mistakenly associated with either unidentified Coleoptera (original description) or Oliera argentinana Br糨es (recently), a distinct cecidosid species with distribution restricted to the eastern Andes. Galls of O. saizi had been undetected, as they are inconspicuous. They occur under the bark within swollen stems, and may occur on the same plant, adjacent to those of A. parrai. We also propose a time-calibrated phylogeny using sequences from mitochondrial and nuclear loci, including specimens of the new proposed taxa. Thus in addition to clarifying the taxonomy of the Chilean cecidosid species we also tested their monophyly in comparison to congeneric species and putative specimens of all genera of Neotropical and African cecidosids.Fil: Silva, Gabriela T.. Universidade Federal do Rio Grande do Sul; BrasilFil: Moreira, Gilson R. P.. Universidade Federal do Rio Grande do Sul; BrasilFil: Vargas, Héctor A.. Universidad de Tarapacá de Arica; ChileFil: Gonçalves, Gislene L.. Universidade Federal do Rio Grande do Sul; Brasil. Universidad de Tarapacá de Arica; ChileFil: Mainardi, Marina D.. Universidade Federal do Rio Grande do Sul; BrasilFil: San Blas, Diego German. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de La Pampa; ArgentinaFil: Davis, Donald. National Museum of Natural History; Estados Unido

Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials

Although over 13 billion COVID-19 vaccine doses have been administered globally, the issue of whether the optimal doses are being used has received little attention. To address this question we reviewed the reports of early-phase dose-finding trials of the nine COVID-19 vaccines approved by World Health Organization, extracting information on study design and findings on reactogenicity and early humoral immune response. The number of different doses evaluated for each vaccine varied widely (range 1-7), as did the number of subjects studied per dose (range 15-190). As expected, the frequency and severity of adverse reactions generally increased at higher doses, although most were clinically tolerable. Higher doses also tended to elicit better immune responses, but differences between the highest dose and the second-highest dose evaluated were small, typically less than 1.6-fold for both binding antibody concentration and neutralising antibody titre. All of the trials had at least one important design limitation - few doses evaluated, large gaps between adjacent doses, or an inadequate sample size - although this is not a criticism of the study investigators, who were working under intense time pressures at the start of the epidemic. It is therefore open to question whether the single dose taken into clinical efficacy trials, and subsequently authorised by regulatory agencies, was optimal. In particular, our analysis indicates that the recommended doses for some vaccines appear to be unnecessarily high. Although reduced dosing for booster injections is an active area of research, the priming dose also merits study. We conclude by suggesting improvements in the design of future vaccine trials, for both next-generation COVID-19 vaccines and for vaccines against other pathogens

Logarithmic behavior of degradation dynamics in metal--oxide semiconductor devices

In this paper the authors describe a theoretical simple statistical modelling of relaxation process in metal-oxide semiconductor devices that governs its degradation. Basically, starting from an initial state where a given number of traps are occupied, the dynamics of the relaxation process is measured calculating the density of occupied traps and its fluctuations (second moment) as function of time. Our theoretical results show a universal logarithmic law for the density of occupied traps $\bar{} \sim \phi (T,E_{F}) (A+B \ln t)$, i.e., the degradation is logarithmic and its amplitude depends on the temperature and Fermi Level of device. Our approach reduces the work to the averages determined by simple binomial sums that are corroborated by our Monte Carlo simulations and by experimental results from literature, which bear in mind enlightening elucidations about the physics of degradation of semiconductor devices of our modern life

Very Small Strangelets

We study the stability of small strangelets by employing a simple model of strange matter as a gas of non-interacting fermions confined in a bag. We solve the Dirac equation and populate the energy levels of the bag one quark at a time. Our results show that for system parameters such that strange matter is unbound in bulk, there may still exist strangelets with $A<100$ that are stable and/or metastable. The lifetime of these strangelets may be too small to detect in current accelerator experiments, however.Comment: 13 pages, MIT CTP#217

Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdon: multicentre cohort study

Objectives: To investigate whether there is evidence that an increasing proportion of HIV infected patients is starting to experience increases in viral load and decreases in CD4 cell count that are consistent with exhaustion of available treatment options. Design: Multicentre cohort study. Setting: Six large HIV treatment centres in southeast England. Participants: All individuals seen for care between 1 January 1996 and 31 December 2002. Main outcome measures: Exposure to individual antiretroviral drugs and drug classes, CD4 count, plasma HIV RNA burden. Results: Information is available on 16 593 individuals (13 378 (80.6%) male patients, 10 340 (62.3%) infected via homosexual or bisexual sex, 4426 (26.7%) infected via heterosexual sex, median age 34 years). Overall, 10 207 of the 16 593 patients (61.5%) have been exposed to any antiretroviral therapy. This proportion increased from 41.2% of patients under follow up at the end of 1996 to 71.3% of those under follow up in 2002. The median CD4 count and HIV RNA burden of patients under follow up in each year changed from 270 cells/mm3 and 4.34 log10 copies/ml in 1996 to 408 cells/mm3 and 1.89 log10 copies/ml, respectively, in 2002. By 2002, 3060 (38%) of patients who had ever been treated with antiretroviral therapy had experienced all three main classes. Of these, around one quarter had evidence of “viral load failure” with all these three classes. Patients with three class failure were more likely to have an HIV RNA burden > 2.7 log10 copies/ml and a CD4 count < 200 cells/mm3. Conclusions: The proportion of individuals with HIV infection in the United Kingdom who have been treated has increased gradually over time. A substantial proportion of these patients seem to be in danger of exhausting their options for antiretroviral treatment. New drugs with low toxicity, which are not associated with cross resistance to existing drugs, are urgently needed for such patients